Company Performance Metrics
- Taek Jung Sang: CTA
- Tae-erk Kim: CEO & Co-Founder
CrossPoint Therapeutics is a therapeutics company that specializes in drug development by using Stealth-Body with antibody source technology. This is a company that prioritizes patient health and aims to become a leader in new drug development using proprietary Stealth-Body antibody source technology. CrossPoint Therapeutics, through its
Stealth-Body antibody source technology New treatments for intractable diseases with unmet clinical demand We are striving to develop and provide patients with a pain-free life. CrossPoint Therapeutics not only provides patients with dignity and a better life not to develop drugs that expand the range of treatable diseases. Developing various innovative new drugs by applying Stealth-Body antibody source technology, It will provide new hope to patients.